Evidence Based Medicine on FHIR Implementation Guide
2.0.0-ballot - ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

: GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA - TTL Representation

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:EvidenceVariable ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "236950"] ; # 
  fhir:meta [
fhir:versionId [ fhir:v "67" ] ;
fhir:lastUpdated [ fhir:v "2024-12-14T08:46:28.847Z"^^xsd:dateTime ] ;
    ( fhir:profile [
fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/uv/ebm/StructureDefinition/group-assignment>     ] )
  ] ; # 
  fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: EvidenceVariable 236950</b></p><a name=\"236950\"> </a><a name=\"hc236950\"> </a><a name=\"236950-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">version: 67; Last updated: 2024-12-14 08:46:28+0000</p><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-group-assignment.html\">GroupAssignment</a></p></div><p><b>url</b>: <a href=\"https://fevir.net/resources/EvidenceVariable/236950\">https://fevir.net/resources/EvidenceVariable/236950</a></p><p><b>identifier</b>: FEvIR Object Identifier/https://fevir.net/FOI/236950, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-group-assignment-85394-85798</p><p><b>name</b>: GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA</p><p><b>title</b>: GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA</p><p><b>status</b>: Active</p><p><b>publisher</b>: Computable Publishing LLC</p><p><b>contact</b>: <a href=\"mailto:support@computablepublishing.com\">support@computablepublishing.com</a></p><p><b>description</b>: </p><div><p>This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide.</p>\n</div><p><b>copyright</b>: </p><div><p>https://creativecommons.org/licenses/by-nc-sa/4.0/</p>\n</div><p><b>author</b>: Computable Publishing®: MAGIC-to-FEvIR Converter: </p><h3>RelatedArtifacts</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>ResourceReference</b></td></tr><tr><td style=\"display: none\">*</td><td>Part Of</td><td>MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)</td></tr></table><h3>Definitions</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://fevir.net/resources/CodeSystem/179423 defined-in-handling-and-category}\">Defined in handling and category elements</span></td></tr></table><p><b>handling</b>: dichotomous variable</p><blockquote><p><b>category</b></p><p><b>name</b>: SGLT2 inhibitors</p><p><b>value</b>: <a href=\"Group-236769.html\">Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors</a></p></blockquote><blockquote><p><b>category</b></p><p><b>name</b>: GLP-1 RA</p><p><b>value</b>: <a href=\"Group-236776.html\">Glucagon-Like Peptide-1 (GLP-1) receptor agonists</a></p></blockquote></div>"
  ] ; # 
  fhir:url [ fhir:v "https://fevir.net/resources/EvidenceVariable/236950"^^xsd:anyURI] ; # 
  fhir:identifier ( [
fhir:type [
      ( fhir:coding [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v2-0203"^^xsd:anyURI ] ;
fhir:code [ fhir:v "ACSN" ] ;
fhir:display [ fhir:v "Accession ID" ]       ] ) ;
fhir:text [ fhir:v "FEvIR Object Identifier" ]     ] ;
fhir:system [ fhir:v "urn:ietf:rfc:3986"^^xsd:anyURI ] ;
fhir:value [ fhir:v "https://fevir.net/FOI/236950" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]     ]
  ] [
fhir:type [
fhir:text [ fhir:v "FEvIR Linking Identifier" ]     ] ;
fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ] ;
fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-group-assignment-85394-85798" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]     ]
  ] ) ; # 
  fhir:name [ fhir:v "GroupAssignment_SGLT2_inhibitors_vs_GLP_1_RA"] ; # 
  fhir:title [ fhir:v "GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA"] ; # 
  fhir:status [ fhir:v "active"] ; # 
  fhir:publisher [ fhir:v "Computable Publishing LLC"] ; # 
  fhir:contact ( [
    ( fhir:telecom [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "support@computablepublishing.com" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "This EvidenceVariable Resource is referenced in an example for the EBMonFHIR Implementation Guide."] ; # 
  fhir:copyright [ fhir:v "https://creativecommons.org/licenses/by-nc-sa/4.0/"] ; # 
  fhir:author ( [
fhir:name [ fhir:v "Computable Publishing®: MAGIC-to-FEvIR Converter" ]
  ] ) ; # 
  fhir:relatedArtifact ( [
fhir:type [ fhir:v "part-of" ] ;
fhir:resourceReference [
fhir:type [ fhir:v "Composition"^^xsd:anyURI ] ;
fhir:identifier [
fhir:type [
fhir:text [ fhir:v "FEvIR Linking Identifier" ]         ] ;
fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ] ;
fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-conversion-report" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]         ]       ] ;
fhir:display [ fhir:v "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes" ]     ]
  ] ) ; # 
  fhir:definition [
fhir:concept [
      ( fhir:coding [
fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ] ;
fhir:code [ fhir:v "defined-in-handling-and-category" ] ;
fhir:display [ fhir:v "Defined in handling and category elements" ]       ] )     ]
  ] ; # 
  fhir:handling [ fhir:v "dichotomous"] ; # 
  fhir:category ( [
fhir:name [ fhir:v "SGLT2 inhibitors" ] ;
fhir:value [
a fhir:Reference ;
fhir:reference [ fhir:v "Group/236769" ] ;
fhir:type [ fhir:v "Group"^^xsd:anyURI ] ;
fhir:identifier [
fhir:type [
fhir:text [ fhir:v "FEvIR Linking Identifier" ]         ] ;
fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ] ;
fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-intervention-85394-I-85798" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]         ]       ] ;
fhir:display [ fhir:v "Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors" ]     ]
  ] [
fhir:name [ fhir:v "GLP-1 RA" ] ;
fhir:value [
a fhir:Reference ;
fhir:reference [ fhir:v "Group/236776" ] ;
fhir:type [ fhir:v "Group"^^xsd:anyURI ] ;
fhir:identifier [
fhir:type [
fhir:text [ fhir:v "FEvIR Linking Identifier" ]         ] ;
fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ] ;
fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-comparator-85394-C-85798" ] ;
fhir:assigner [
fhir:display [ fhir:v "Computable Publishing LLC" ]         ]       ] ;
fhir:display [ fhir:v "Glucagon-Like Peptide-1 (GLP-1) receptor agonists" ]     ]
  ] ) . #